Scotland's national naloxone program: the prison experience

Kirsten Horsburgh, Andrew McAuley

Research output: Contribution to journalArticle

10 Downloads (Pure)

Abstract

Launched in 2011, the Scottish national naloxone program marked an important development in public health policy. Central to its design were strategies to engage prisoners given their elevated risk of drug-related death in the weeks following liberation. Implementation across Scottish prisons has posed particular challenges linked to both operational issues within prison establishments and individual factors affecting staff delivering, and prisoners engaging, with the program. Barriers have been overcome through innovation and partnership working. This commentary has described how the development of the program in prisons has adapted to these challenges to a point where a largely consistent model is in place and where prisoners-on-release are reaping the benefits in terms of reduced opioid-related mortality.
Original languageEnglish
Pages (from-to)454-456
Number of pages3
JournalDrug and Alcohol Review
Volume37
Issue number4
Early online date10 Apr 2017
DOIs
Publication statusPublished - May 2018

Fingerprint

Prisoners
Prisons
Scotland
Naloxone
prisoner
correctional institution
experience
Program Development
Public Policy
Health Policy
liberation
health policy
Opioid Analgesics
mortality
Public Health
public health
innovation
drug
staff
death

Keywords

  • national naloxone program
  • Scotland
  • prisoners
  • drug-related deaths
  • naloxone
  • prison
  • overdose
  • mortality

Cite this

@article{5db98433d1a24fff93512fa99456ba3e,
title = "Scotland's national naloxone program: the prison experience",
abstract = "Launched in 2011, the Scottish national naloxone program marked an important development in public health policy. Central to its design were strategies to engage prisoners given their elevated risk of drug-related death in the weeks following liberation. Implementation across Scottish prisons has posed particular challenges linked to both operational issues within prison establishments and individual factors affecting staff delivering, and prisoners engaging, with the program. Barriers have been overcome through innovation and partnership working. This commentary has described how the development of the program in prisons has adapted to these challenges to a point where a largely consistent model is in place and where prisoners-on-release are reaping the benefits in terms of reduced opioid-related mortality.",
keywords = "national naloxone program, Scotland, prisoners, drug-related deaths , naloxone, prison, overdose, mortality",
author = "Kirsten Horsburgh and Andrew McAuley",
note = "Acceptance from webpage Missed output for REF scope validation - deposit requirement met but access not met. ET 31/10/19 Applied 'no exception' re access date. ET 31/10/19 Paper not available in other repository - checked 31/10/19 ET",
year = "2018",
month = "5",
doi = "10.1111/dar.12542",
language = "English",
volume = "37",
pages = "454--456",
journal = "Drug and Alcohol Review",
issn = "0959-5236",
publisher = "John Wiley & Sons",
number = "4",

}

Scotland's national naloxone program: the prison experience. / Horsburgh, Kirsten; McAuley, Andrew.

In: Drug and Alcohol Review, Vol. 37, No. 4, 05.2018, p. 454-456.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Scotland's national naloxone program: the prison experience

AU - Horsburgh, Kirsten

AU - McAuley, Andrew

N1 - Acceptance from webpage Missed output for REF scope validation - deposit requirement met but access not met. ET 31/10/19 Applied 'no exception' re access date. ET 31/10/19 Paper not available in other repository - checked 31/10/19 ET

PY - 2018/5

Y1 - 2018/5

N2 - Launched in 2011, the Scottish national naloxone program marked an important development in public health policy. Central to its design were strategies to engage prisoners given their elevated risk of drug-related death in the weeks following liberation. Implementation across Scottish prisons has posed particular challenges linked to both operational issues within prison establishments and individual factors affecting staff delivering, and prisoners engaging, with the program. Barriers have been overcome through innovation and partnership working. This commentary has described how the development of the program in prisons has adapted to these challenges to a point where a largely consistent model is in place and where prisoners-on-release are reaping the benefits in terms of reduced opioid-related mortality.

AB - Launched in 2011, the Scottish national naloxone program marked an important development in public health policy. Central to its design were strategies to engage prisoners given their elevated risk of drug-related death in the weeks following liberation. Implementation across Scottish prisons has posed particular challenges linked to both operational issues within prison establishments and individual factors affecting staff delivering, and prisoners engaging, with the program. Barriers have been overcome through innovation and partnership working. This commentary has described how the development of the program in prisons has adapted to these challenges to a point where a largely consistent model is in place and where prisoners-on-release are reaping the benefits in terms of reduced opioid-related mortality.

KW - national naloxone program

KW - Scotland

KW - prisoners

KW - drug-related deaths

KW - naloxone

KW - prison

KW - overdose

KW - mortality

U2 - 10.1111/dar.12542

DO - 10.1111/dar.12542

M3 - Article

VL - 37

SP - 454

EP - 456

JO - Drug and Alcohol Review

JF - Drug and Alcohol Review

SN - 0959-5236

IS - 4

ER -